Announcements Trials
Browse Landscape

Phase

Phase 2 5

Status

Completed 4Terminated 1

Sponsor Class

OTHER 5NIH 2

Study Type

Interventional 5

Sponsor

Cancer Type

Gastrointestinal 5

Conditions

Colorectal Neoplasms 26Breast Neoplasms 21Carcinoma, Non-Small-Cell Lung 19Lung Neoplasms 15Head and Neck Neoplasms 13Rectal Neoplasms 11Colonic Neoplasms 11Prostatic Neoplasms 8Pancreatic Neoplasms 7Mouth Neoplasms 6Glioblastoma 6Neuroblastoma 5Neoplasm Metastasis 5Esophageal Neoplasms 5Central Nervous System Neoplasms 5Carcinoma 5Unspecified Adult Solid Tumor, Protocol Specific 4Triple Negative Breast Neoplasms 4Recurrence 4Precancerous Conditions 4Ovarian Neoplasms 4Oropharyngeal Neoplasms 4Neoplasms 4Liver Neoplasms 4Laryngeal Neoplasms 4Hypopharyngeal Neoplasms 4Gliosarcoma 4Carcinoma, Hepatocellular 4Adenomatous Polyposis Coli 4Sarcoma 3

Interventions

Cisplatin 109Radiotherapy 100Fluorouracil 90Paclitaxel 75Oxaliplatin 63Docetaxel 56Carboplatin 55Irinotecan 41Esophagectomy 41Leucovorin 40Capecitabine 39Surgical Procedures, Operative 36Radiation 36Drug Therapy 31Neoadjuvant Therapy 25Chemoradiotherapy 18Cetuximab 18S 1 (combination) 17pembrolizumab 16camrelizumab 16Nivolumab 15Magnetic Resonance Spectroscopy 15Bevacizumab 15Blood Specimen Collection 14Surveys and Questionnaires 12Radiotherapy, Intensity-Modulated 12Immunotherapy 11Epirubicin 11Biopsy 11Trastuzumab 10

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

5 trials
RecentStart dateEnrollment
OTHER × Esophageal Neoplasms × Celecoxib × Clear all
NCT00137852 2017-09-20

Cisplatin, CPT-11 and Celecoxib With Radiation Therapy and Surgery for Operable Esophageal Cancer

Dana-Farber Cancer Institute

Phase 2 Completed
35 enrolled
Gastrointestinal

Esophageal Neoplasms

NCT00005878 2016-10-13

Celecoxib to Prevent Cancer in Patients With Barrett's Esophagus

Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins

Phase 2 Completed
Gastrointestinal

Esophageal Neoplasms

NCT00183807 2014-05-22

A Study of Irinotecan, Cisplatin and Celebrex in Patients With Metastatic or Unresectable Esophageal Cancer

University of Southern California

Phase 2 Terminated
6 enrolled
Gastrointestinal

Esophageal Neoplasms

NCT00520091 2012-05-18

Irinotecan, Cisplatin, and Radiation Therapy With or Without Celecoxib in Treating Patients With Stage II, Stage III, or Stage IV Esophageal Cancer

UNC Lineberger Comprehensive Cancer Center

Phase 2 Completed
14 enrolled
Gastrointestinal

Adenocarcinoma Of Esophagus, Esophageal Squamous Cell Carcinoma, Esophageal Neoplasms

NCT00066716 2009-12-08

Celecoxib, Paclitaxel, and Carboplatin in Treating Patients With Cancer of the Esophagus

Weill Medical College of Cornell University

Phase 2 Completed
39 enrolled
Gastrointestinal

Adenocarcinoma Of Esophagus, Esophageal Squamous Cell Carcinoma, Esophageal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡